Anthem Biosciences IPO Allotment (July 17): How to check status on BSE, NSE, and registrar KFin Tech Anthem Biosciences IPO: Once shares are allotted, successful bidders will receive shares in their ...

Ensysce Biosciences Initiates Pivotal Phase 3 Study of PF614 - A Next-Generation Opioid - Designed to Deliver Powerful Pain Relief and Reduce Abuse ~ FDA Protocol Review Completed ~ ~ Rho, Inc.

Anthem Biosciences IPO subscription was led by the Non-institutional Investors category garnering 2.82 times subscription, while the quota for Retail Individual Investors (RIIs) got subscribed 89 ...

Integrated Biosciences, a biotechnology company integrating optogenetics, chemistry and AI to discover small molecule therapeutics for age-related diseases, ...

Pacira BioSciences Inc. (NASDAQ:PCRX) is one of the most undervalued small-cap stocks to buy according to analysts.

Genetic engineering startup Colossal Biosciences has added the South Island giant moa — a powerful, long-necked species that stood 10 feet (3 meters) tall and may have kicked in self-defense ...

Concentra Biosciences continues to scavenge for struggling biotechs, this time picking up antibody biotech IGM Biosciences for $1.25 per share.

Colossal Biosciences: 2025 TIME100 Most Influential CompaniesExtinction ain’t what it used to be. Around one-third of all existing species could vanish due to global warming by 2050 according to ...

Ratings for Pacific Biosciences PACB were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of ...

Colossal Biosciences' successful creation of dire wolves forces us to confront these questions in ways that are both thrilling and unsettling.

Kronos Bio completed its sale to Concentra Biosciences for 57 cents a share in cash plus contingent value rights related to cost savings and potential proceeds from disposition of drug candidates.